Clinical Trials Browser

OTHER × Prostate Cancer Metastatic × Docetaxel × Clear all

NCT02913196 2026-04-20

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Phase 1 Completed

Prostate Cancer Metastatic

NCT06320067 2025-09-26

STAMPEDE2

Phase 3 Recruiting

Prostate Cancer Metastatic